Reflecting on- and Looking Ahead After- OCT DACH 2025

On 12-13 November 2025, 2KMM exhibited at the 8th Annual Outsourcing in Clinical Trials (OCT) DACH conference, organized by Arena International in Zurich. This was our second time attending this premier event, further strengthening our commitment to the clinical-trials ecosystem in the DACH region.

Over two days, around 250 industry leaders convened to address key operational challenges in clinical development - from established technology solutions to the growing impact of AI-powered trials.

A particularly valuable aspect of the event was the high quality of networking. We were pleased to connect with many new stakeholders, including senior decision-makers from pharmaceutical, biotechnology, medical device companies, as well as CROs and technology providers. The conversations we had - which offered an opportunity not only to get to know one another but also to exchange numerous insights - reinforced our belief in the benefits that potential partnerships and collaboration on future projects could bring.

We are already looking forward to next year’s OCT Europe, which will take place in Barcelona on 6–7 May 2026.

Our participation at OCT DACH was made possible through cooperation with the MedSilesia Cluster as part of the SmartMed project.